Company news
Little Green Pharma Ltd. (ASX:LGP) news
Little Green Pharma Ltd. news releases on 6ix. Latest, May 31, 2026: Implementation of Merger between LGP and Cannatrek
Press releases & updates
Implementation of Merger between LGP and Cannatrek
May 31, 2026
Court Approves the Scheme and Scheme Becomes Effective
May 25, 2026
Appendix 4E and 2026 Annual Report
May 20, 2026
Transaction Update and General Meeting Update
May 10, 2026
Updated second court date and indicative timetable
April 23, 2026
Scheme Update
April 21, 2026
Scheme Approved by Cannatrek Shareholders
April 10, 2026
Supplementary Scheme Booklet
March 31, 2026
Termination of proposed sale and leaseback transaction
March 18, 2026
Scheme Booklet Registered by ASIC
March 4, 2026
Proposed sale of WA production facility
February 18, 2026
Quarterly Activities Report and Appendix 4C
January 29, 2026
Transformational Merger of LGP and Cannatrek
January 13, 2026
US Executive Order to reschedule cannabis
December 22, 2025
Half Yearly Report and Accounts
November 20, 2025
Appendix 4E and 2025 Annual Report
May 29, 2025
LGP Board changes
March 2, 2025
LGP signs acquisition agreement for Health House
February 4, 2025
LGP to acquire Health House distribution business
December 19, 2024
Denmark positioned as EU medicinal cannabis hub
December 4, 2024
Cleansing Notice
October 16, 2024
Appendix 4E and 2024 Annual Report
May 30, 2024
US Reschedules Cannabis
May 1, 2024
Quarterly Activities Report & Appendix 4C
April 16, 2024
Germany Legalises Cannabis
February 25, 2024
Reset Offers withdrawn and Reset to remain LGP subsidiary
February 18, 2024
LGP receives $5 million R&D rebate
January 31, 2024
LGP to capitalise on new French cannabis healthcare laws
December 6, 2023
Reset Mind Sciences - Investor Presentation
November 19, 2023
Long Form Prospectus
November 9, 2023
Short Form Prospectus
November 9, 2023
Notice of General Meeting
November 9, 2023
Change in Leadership at Little Green Pharma
August 15, 2023
Desert Flame granted Polish Marketing Authorisation
August 1, 2023
LGP Awarded French trial tender for CBD50
July 11, 2023
Preliminary Final Report
May 31, 2023
LGP wins extended French government tender
May 7, 2023
First shipment to Ilios Sante in Germany
April 16, 2023
Successful completion of $5 million placement
March 23, 2023
Trading Halt
March 21, 2023
Reset Mind Sciences and HIF enter Strategic Alliance
March 21, 2023
Ethics approval granted for psilocybin clinical trial
February 14, 2023
Psilocybin and MDMA down-scheduled
February 6, 2023
Share Purchase Plan offer extended to 16 January 2023
December 18, 2022
Second exclusive supply agreement with Cannamedical
December 1, 2022
Ethics approval for CBD Phase III clinical trial
November 29, 2022
LGP significantly expands flower portfolio
November 23, 2022
Prospectus
November 20, 2022
Share Purchase Plan open to eligible shareholders
November 20, 2022
Update Four 20 Pharma and French trial extension
November 20, 2022